Hem/Onc Quiz #31: Antineoplastic Pharmacology and Pharmacotherapies

1. A 58-year-old man with chronic myelogenous leukemia (CML) is started on a medication that specifically targets the BCR-ABL tyrosine kinase. Which of the following drugs is most likely being used in his treatment?

Question 1 of 5

2. A patient with non-small cell lung cancer (NSCLC) harboring an EGFR mutation is treated with a targeted therapy. Which of the following drugs is most likely to be effective in this setting? 

Question 2 of 5

3. A 45-year-old woman with breast cancer is started on a chemotherapy regimen that includes a drug known for causing cardiotoxicity through free radical damage. Which of the following drugs is she most likely receiving? 

Question 3 of 5

4. A patient diagnosed with metastatic colorectal cancer is to start a chemotherapy regimen that includes a drug targeting the enzyme involved in the synthesis of thymidylate, an essential precursor for DNA synthesis. Which of the following drugs is most likely included in his regimen? 

Question 4 of 5

5. A 55-year-old man with metastatic melanoma has a tumor that tests positive for a V600E BRAF mutation. Which of the following targeted therapies is most appropriate for his condition? 

Question 5 of 5


 

¡Por tiempo limitado!

Unete a nuestro boletín mensual y obtén todos nuestros talleres USMLE/ECFMG ¡GRATIS! (+100 videos)

¡Únete a nuestra comunidad de IMGs!

¡Obtén actualizaciones mensuales USMLE y ECFMG, además, obtén un taller USMLE gratis al instante!

"Taller 01: ¿Qué es el USMLE?”

Taller Gratuito USMLE

Este taller proporciona un análisis en profundidad de todos los exámenes USMLE, consejos para tomar exámenes y cómo estudiar de manera efectiva.

OFERTA POR TIEMPO LIMITADO

Especialista ECFMG: Dr. Carla Rebeca Lainez Casal

Facultad de Medicina: Universidad Catholica de Santiago de Guayaquil
ECFMG Certification date: October 13, 2022.
Residency: 2023 Internal Medicine Applicant
+1 7542724970